Search for Clinical Trial Results
Carcinoma, Medullary - 17 Studies Found
Status | Study |
Terminated |
Study Name: Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer Condition:
|
Active, not recruiting |
Study Name: Sorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid Cancer Condition:
|
Recruiting |
Study Name: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Condition:
Interventions: Drug: Pazopanib Hydrochloride Given PO Other Names: |
Active, not recruiting |
Study Name: Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer Condition:
Interventions: |
Active, not recruiting |
Study Name: Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors Condition:
|
Completed |
Study Name: Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer Condition:
|
Recruiting |
Study Name: A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma Condition:
|
Recruiting |
Study Name: Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer Condition:
|
Completed |
Study Name: Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma Condition:
|